Citigroup Inc Zai Lab LTD Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Zai Lab LTD stock. As of the latest transaction made, Citigroup Inc holds 69,747 shares of ZLAB stock, worth $1.83 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

69,747

Previous 105,003 33.58%

Holding current value

$1.83 Million

Previous $1.82 Million 7.48%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$16.25 - $24.14 $572,910 - $851,079	-35,256 Reduced 33.58%	69,747 $1.68 Million
Q2 2024 Aug 12, 2024	BUY	$13.72 - $21.55 $1.42 Million - $2.22 Million	103,244 Added 5869.47%	105,003 $1.82 Million
Q1 2024 May 10, 2024	SELL	$15.95 - $26.8 $14,689 - $24,682	-921 Reduced 34.37%	1,759 $28,000
Q4 2023 Feb 09, 2024	SELL	$22.97 - $30.58 $2.82 Million - $3.76 Million	-122,808 Reduced 97.86%	2,680 $73,000
Q3 2023 Nov 09, 2023	SELL	$22.72 - $31.49 $5,225 - $7,242	-230 Reduced 0.18%	125,488 $3.05 Million
Q2 2023 Aug 10, 2023	SELL	$25.3 - $39.67 $9.79 Million - $15.3 Million	-386,852 Reduced 75.47%	125,718 $3.49 Million
Q1 2023 May 11, 2023	BUY	$30.21 - $48.1 $13.5 Million - $21.5 Million	446,515 Added 675.97%	512,570 $17 Million
Q4 2022 Feb 09, 2023	SELL	$22.28 - $38.71 $979,116 - $1.7 Million	-43,946 Reduced 39.95%	66,055 $2.03 Million
Q3 2022 Nov 10, 2022	SELL	$34.2 - $51.69 $491,248 - $742,475	-14,364 Reduced 11.55%	110,001 $3.76 Million
Q2 2022 Aug 10, 2022	BUY	$23.14 - $49.68 $3,424 - $7,352	148 Added 0.12%	124,365 $4.31 Million
Q1 2022 May 12, 2022	BUY	$27.77 - $64.4 $2.43 Million - $5.63 Million	87,400 Added 237.39%	124,217 $5.46 Million
Q4 2021 Feb 10, 2022	SELL	$54.9 - $105.21 $79,001 - $151,397	-1,439 Reduced 3.76%	36,817 $2.31 Million
Q3 2021 Nov 10, 2021	BUY	$105.0 - $178.37 $4.02 Million - $6.82 Million	38,256 New	38,256 $4.03 Million

Others Institutions Holding ZLAB

# of Institutions

123

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account